Michael Burry Takes Another Huge Short Position on Nvidia and Palantir After Bubble Warning
TLDR
- Michael Burry’s Scion Asset Management purchased put options on Nvidia worth $187 million and Palantir worth $912 million in Q3 2025.
- The two put positions together represent 80% of Scion’s portfolio at the end of September.
2 Top Growth Stocks to Buy Hand Over Fist in November
Key Points
-
Tech companies are beginning to incorporate AI and robotics into their business models.
-
At Amazon,
» Read more about: 2 Top Growth Stocks to Buy Hand Over Fist in November »
Read MoreWill These 2 Robotics ETFs Surge 50% or More as the AI Revolution Takes Off?
Robotics is an interesting opportunity, but choosing individual stocks isn’t for everyone.
Much of the stock market’s attention is focused on artificial intelligence, or AI, and for good reason. AI could be the most important technological revolution of our lifetimes, and the surge in AI investment has already made many investors a lot of money.
» Read more about: Will These 2 Robotics ETFs Surge 50% or More as the AI Revolution Takes Off? »
Read MoreDow Jones Today: Stock Futures Point Sharply Lower; Palantir Leads Tech Share Declines
Stock futures pointed sharply lower Tuesday, with shares of Palantir Technologies leading declines even though the AI software firm reported strong quarterly results.
Futures associated with the tech-heavy Nasdaq, benchmark S&P 500, and blue-chip Dow Jones Industrial Average were down 1.3%, 1%, and 0.6%,
Read MoreMistras Group (MG): One-Off $8.6M Loss Challenges Bullish Profitability Narrative
Mistras Group (MG) recently reported a major shift to profitability, with earnings averaging 71.1% growth each year over the past five years and the company’s net profit margin moving into positive territory during the last year. Shares are currently trading at $11.79, well below an estimated fair value of $22.02 based on the discounted cash flow approach.
The Burst
1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read MoreThe Ivy
Shopify’s Billion-Dollar Milestone: Is This a Golden Buying Opportunity?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and payment processor that is used by millions of online merchants worldwide.
Like many tech companies, Shopify has seen its stock price tumble in recent weeks, with the stock’s 30-day losses currently sitting at 27.3%.
» Read more about: Shopify’s Billion-Dollar Milestone: Is This a Golden Buying Opportunity? »
Read MoreThe Spotlight
Spotlight: AI + Robotics = 4x Growth
Google. Apple. Amazon. Microsoft. They are all investing in AI but one company you probably have not heard about is Symbiotic, a warehousing automation firm that combines advanced robotics with artificial intelligence.
It’s one of those businesses that’s hard to wrap your head around at first but it’s been a huge hit on Wall Street.